{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=2&page=82", "query": { "intervention": "2", "page": 82 }, "page_size": 10 }, "pagination": { "page": 82, "page_size": 10, "total_count": 79351, "total_pages": 7936, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=2&page=83&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=2&page=81&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-10T07:21:16.687Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00660881", "title": "Open-label Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus Patients With Active Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Systemic Lupus Erythematosus" ], "interventions": [ { "name": "Epratuzumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "UCB Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 210, "start_date": "2008-05", "completion_date": "2011-12", "has_results": false, "last_update_posted_date": "2012-07-12", "last_synced_at": "2026-11-10T07:21:16.687Z", "location_count": 14, "location_summary": "Birmingham, Alabama • Tucson, Arizona • La Jolla, California + 11 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Leandro", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00660881" }, { "nct_id": "NCT01558830", "title": "Safety of Amiodarone and Ranolazine Together in Patients With Angina", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Chronic Stable Angina", "Coronary Artery Disease", "Atrial Fibrillation", "Ventricular Tachycardia" ], "interventions": [ { "name": "ranolazine", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cardiovascular Consultants of Nevada", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": null, "sex": "ALL", "summary": "35 Years and older" }, "enrollment_count": 50, "start_date": "2012-01", "completion_date": "2013-07", "has_results": false, "last_update_posted_date": "2012-03-21", "last_synced_at": "2026-11-10T07:21:16.687Z", "location_count": 3, "location_summary": "Henderson, Nevada • Las Vegas, Nevada", "locations": [ { "city": "Henderson", "state": "Nevada" }, { "city": "Las Vegas", "state": "Nevada" }, { "city": "Las Vegas", "state": "Nevada" } ], "official_url": "https://clinicaltrials.gov/study/NCT01558830" }, { "nct_id": "NCT06066528", "title": "A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Obesity", "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "Survodutide", "type": "COMBINATION_PRODUCT" }, { "name": "Placebo", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 755, "start_date": "2023-11-27", "completion_date": "2026-04-01", "has_results": false, "last_update_posted_date": "2026-08-06", "last_synced_at": "2026-11-10T07:21:16.687Z", "location_count": 34, "location_summary": "Anniston, Alabama • Phoenix, Arizona • Spring Valley, California + 31 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Spring Valley", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Doral", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06066528" }, { "nct_id": "NCT01383928", "title": "Study of Oral IXAZOMIB in Combination With Lenalidomide and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Multiple Myeloma" ], "interventions": [ { "name": "Ixazomib", "type": "DRUG" }, { "name": "Lenalidomide", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Millennium Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 64, "start_date": "2011-10-31", "completion_date": "2017-11-27", "has_results": true, "last_update_posted_date": "2019-03-21", "last_synced_at": "2026-11-10T07:21:16.687Z", "location_count": 20, "location_summary": "Berkeley, California • Duarte, California • Stanford, California + 15 more", "locations": [ { "city": "Berkeley", "state": "California" }, { "city": "Duarte", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01383928" }, { "nct_id": "NCT07501065", "title": "Prophylactic Antibiotics for Outpatient Urethral Bulking", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Urinary Tract Infections", "Stress Urinary Incontinence", "Urinary Incontinence" ], "interventions": [ { "name": "Bactrim (800/160 mg), Keflex (500 mg), Cipro (250 mg), or Macrobid (100mg)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Miami", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 150, "start_date": "2026-08-19", "completion_date": "2028-12", "has_results": false, "last_update_posted_date": "2026-10-29", "last_synced_at": "2026-11-10T07:21:16.687Z", "location_count": 2, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07501065" }, { "nct_id": "NCT07493265", "title": "A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Narcolepsy" ], "interventions": [ { "name": "E2086", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eisai Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 64, "start_date": "2026-03-26", "completion_date": "2027-03-01", "has_results": false, "last_update_posted_date": "2026-05-14", "last_synced_at": "2026-11-10T07:21:16.687Z", "location_count": 17, "location_summary": "Santa Ana, California • Brandon, Florida • Medley, Florida + 12 more", "locations": [ { "city": "Santa Ana", "state": "California" }, { "city": "Brandon", "state": "Florida" }, { "city": "Medley", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07493265" }, { "nct_id": "NCT03669965", "title": "KRT-232 Compared to Ruxolitinib in Patients With Phlebotomy-Dependent Polycythemia Vera", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Polycythemia Vera" ], "interventions": [ { "name": "KRT-232", "type": "DRUG" }, { "name": "Ruxolitinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kartos Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2019-01-15", "completion_date": "2022-10", "has_results": false, "last_update_posted_date": "2020-07-31", "last_synced_at": "2026-11-10T07:21:16.687Z", "location_count": 5, "location_summary": "Birmingham, Alabama • Los Angeles, California • St Louis, Missouri + 2 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Canton", "state": "Ohio" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03669965" }, { "nct_id": "NCT04050800", "title": "Carbon-11 Butanol: Whole Body Radiochemical and Radiation Safety", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Neuro-Degenerative Disease" ], "interventions": [ { "name": "Carbon 11 Butanol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Weill Medical College of Cornell University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "89 Years", "sex": "ALL", "summary": "18 Years to 89 Years" }, "enrollment_count": 5, "start_date": "2020-09-17", "completion_date": "2021-01-05", "has_results": false, "last_update_posted_date": "2021-06-18", "last_synced_at": "2026-11-10T07:21:16.687Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04050800" }, { "nct_id": "NCT00782600", "title": "Study of Controlled Release Formulations of CE-224,535 Against the Immediate Release Formulation in Normal Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "suspension IR", "type": "DRUG" }, { "name": "CR 1", "type": "DRUG" }, { "name": "CR 2", "type": "DRUG" }, { "name": "CR 3", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 16, "start_date": "2008-07", "completion_date": "2008-08", "has_results": false, "last_update_posted_date": "2009-06-09", "last_synced_at": "2026-11-10T07:21:16.687Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00782600" }, { "nct_id": "NCT05267600", "title": "A Phase 2/3 Study of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Bullous Pemphigoid" ], "interventions": [ { "name": "efgartigimod PH20 SC", "type": "BIOLOGICAL" }, { "name": "placebo", "type": "OTHER" }, { "name": "Prednisone", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "OTHER", "DRUG" ], "sponsor": "argenx", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 98, "start_date": "2022-06-09", "completion_date": "2024-09-13", "has_results": true, "last_update_posted_date": "2025-10-23", "last_synced_at": "2026-11-10T07:21:16.687Z", "location_count": 21, "location_summary": "Phoenix, Arizona • Fountain Valley, California • Redwood City, California + 18 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Redwood City", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Castle Rock", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT05267600" } ] }